Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-001826-99Phase 4Completed
Phase 4, single-arm trial of adalimumab in spondyloarthritis (SpA), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: ASAS50 response at week 24. Started Aug 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-001826-99.